Trial intelligence / Profile preview

Estriol and Hyaluronic Acid for Cervical Preparation in Hysteroscopy

NCT05783479Completed

Sponsor
Jagiellonian University
Start
Jun 2022
Primary completion
Dec 2022
Modality
Hydrogel Systems
Countries
1
01

Overview

Open-label trial of estradiol topical and hyaluronic acid sodium composite gel for injection in genitourinary syndrome of menopause (GSM), sponsored by Jagiellonian University. Primary endpoints: Intensification of pain during the procedure at 6 months and Intensification of pain after the procedure at 6 months. Started Jun 2022; status: completed.

02

Drugs

estradiol topicalhyaluronic acid sodium composite gel for injection
03

Conditions

genitourinary syndrome of menopause (GSM)

Beyond the preview

Go deeper on NCT05783479.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05783479.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call